What is the generic name?

CAPLACIZUMAB

What is the Trade Name for CAPLACIZUMAB?

Cablivi

What are the Indications for CAPLACIZUMAB?

• 1 INDICATIONS AND USAGE CABLIVI is indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy. CABLIVI is a von Willebrand factor (vWF)-directed antibody fragment indicated for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy. ( 1 )

References: https://open.fda.gov/